While the preferential spread of tumours to specific parts of the body has been acknowledged for over a century, more accurate understandings of preferential metastasis have developed with an awareness of tumour biology.

3D models like organoids, spheroids, and organ-on-chip systems recreate human organ architecture and physiology, aiding research, drug development, and disease modelling.

Given the widespread incidence of cancers and cardiovascular diseases, having sufficient means to model their behaviour is vital to the development of new treatments. Maintaining tissue contexts in disease modelling is crucial for developing a comprehensive understanding of how different diseases behave.

3D cell modelling can help develop understandings of disease pathologies, facilitating the investigation of how tissues react to certain treatments without causing undue harm or risk to the patients who need them.

Blueprints for the bioprinter have been made open-access, to ensure greater freedom of use with the device at a time when research funding is harder to come by.